RE: Sierra22 Jan 2022 14:51
This was the RNS on November 2020 when we were stitched up by the experienced guys........
Sareum's CEO, Dr Tim Mitchell, commented:
"We believe this revised agreement between Sierra and CPF clears the way for the further clinical development of SRA737, either internally or through a partner, giving Sareum the potential to benefit from downstream milestone payments.
"While the aggregate level of these milestone payments is reduced, we are confident that this amendment will expedite the advancement of the SRA737 programme in a timely manner. We look forward to further updates on the clinical development of SRA737, a molecule that has shown great promise in clinical trials and preclinical studies, particularly in combination with other types of cancer therapy."
Will it ever happen?